| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 05/21/2009 | US20090131429 Pharmaceutical compounds |
| 05/21/2009 | US20090131428 Benzooxazole-4,7-dione, derivatives and their use as cdc25 phosphate inhibitors |
| 05/21/2009 | US20090131421 Compounds for proteasome enzyme inhibition |
| 05/21/2009 | US20090131419 Which modulates activity of amyloid precursor proteins; Alzheimer's disease |
| 05/21/2009 | US20090131418 Spiroazacyclic compounds as monoamine receptor modulators |
| 05/21/2009 | US20090131417 Substituted pyridyl amide compounds as modulators of the histamine h3 receptor |
| 05/21/2009 | US20090131416 Substituted pyrazinyl amide compounds as modulators of the histamine h3 receptor |
| 05/21/2009 | US20090131415 Cycloalkyloxy-and heterocycloalkyloxypyridine compounds as modulators of the histamine h3 receptor |
| 05/21/2009 | US20090131409 1,4,5,6,7,8-HEXAHYDRO -PYRROLO[2,3-d]AZEPINES AND -IMIDAZO[4,5-d]AZEPINES AS MODULATORS OF NUCLEAR RECEPTOR ACTIVITY |
| 05/21/2009 | US20090131404 Combinations |
| 05/21/2009 | US20090131385 Estriol Therapy for Autoimmune and Neurodegenerative Diseases and Disorders |
| 05/21/2009 | US20090131383 Pharmaceutical compositions of a neuroactive steriod and methods of use thereof |
| 05/21/2009 | US20090131368 Mixtures of and methods of use for polyunsaturated fatty acid-containing phospholipids and alkyl ether phospholipids species |
| 05/21/2009 | US20090131339 Compounds having neuroprotective properties |
| 05/21/2009 | US20090131336 Isoxazole Derivatives and Use Thereof |
| 05/21/2009 | US20090131335 Abuse-resistant amphetamine prodrugs |
| 05/21/2009 | US20090131334 Abuse-resistant amphetamine prodrugs |
| 05/21/2009 | US20090131333 Abuse-resistant amphetamine prodrugs |
| 05/21/2009 | US20090131332 Abuse-resistant amphetamine prodrugs |
| 05/21/2009 | US20090131328 Furin inhibitors |
| 05/21/2009 | US20090131326 Abuse-resistant amphetamine prodrugs |
| 05/21/2009 | US20090131325 Abuse-resistant amphetamine prodrugs |
| 05/21/2009 | US20090131324 Abuse-resistant amphetamine prodrugs |
| 05/21/2009 | US20090131323 Abuse-resistant amphetamine prodrugs |
| 05/21/2009 | US20090131322 Abuse-resistant amphetamine prodrugs |
| 05/21/2009 | US20090131320 Peptides modulating the activity of the engrailed transcription factor |
| 05/21/2009 | US20090130235 Method for marketing vibration medicine products |
| 05/21/2009 | US20090130197 Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt |
| 05/21/2009 | US20090130183 Bilayer Composition for the Sustained Release of Acetaminophen and Tramadol |
| 05/21/2009 | US20090130182 Topical compositions for treating pain |
| 05/21/2009 | US20090130126 Dna expression vectors |
| 05/21/2009 | US20090130081 Method for treating pervasive development disorders |
| 05/21/2009 | US20090130078 Treatment for Cardiovascular Disease |
| 05/20/2009 | EP2060572A1 Pyrazolopyridine derivative and phosphodiesterase (pde) inhibitor containing the same as active ingredient |
| 05/20/2009 | EP2060570A2 Azabicyclo(3.1.0) hexane derivatives useful as modulators of dopamine D3 receptors |
| 05/20/2009 | EP2060267A2 Methods for therapy of neurodegenerative disease of the brain |
| 05/20/2009 | EP2060265A2 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 05/20/2009 | EP2060260A1 Therapeutic agents useful for treating pain |
| 05/20/2009 | EP2059802A2 Methods for designing parp inhibitors and uses thereof |
| 05/20/2009 | EP2059521A1 Pyrazolo[1,5-a]pyrimidines, processes, uses and compositions |
| 05/20/2009 | EP2059520A1 1,4,5,6, 7,8-hexahydro-i^1s-triaza-azulene derivatives as orexin receptor antagonists |
| 05/20/2009 | EP2059506A1 Novel piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 05/20/2009 | EP2059245A1 Bifeprunox doses for treating schizophrenia |
| 05/20/2009 | EP2059244A1 Titration schedule for bifeprunox for treating schizophrenia and kits for use therein |
| 05/20/2009 | EP2059243A1 Buprenophine-wafer for drug substitution therapy |
| 05/20/2009 | EP2059238A2 Therapeutic compounds for diseases and disorders |
| 05/20/2009 | EP2059235A2 Method for prevention and treatment of alzheimers |
| 05/20/2009 | EP1870106B1 Combination of egf/ghrp-6 for neuroregeneration of central nervous system |
| 05/20/2009 | EP1562575B1 Fused cycloalkyl amides and acids and their therapeutic applications for the treatment of i.a. epilepsy |
| 05/20/2009 | EP1513528B1 Pharmaceutical composition containing stabilised amorphous form of donepezil hydrochloride |
| 05/20/2009 | EP1414451B1 Opioid agonist formulations with releasable and sequestered antagonist |
| 05/20/2009 | EP0651789B2 Method for preventing zoster and alleviating varicella related post-herpetic neuralgia |
| 05/20/2009 | DE60226032T2 Neue imidazolidinderivate, deren herstellung und verwendung als vla4-antagonisten New imidazolidine derivatives, their preparation and use as VLA4 antagonists |
| 05/20/2009 | DE102007054653A1 Use of thiourea derivative to degrade advanced glycation end-products, Maillard-products and Amadori products and to prepare medicament to inhibit skin diseases during diabetes and to treat e.g. cataract, arthritis and Alzheimer's disease |
| 05/20/2009 | CN201238911Y Aromatic plant pillow |
| 05/20/2009 | CN101437934A Method of producing dry yeast containing S-adenosyl-L-methionine and composition for oral intake |
| 05/20/2009 | CN101437828A MGLUR1 antagonists as therapeutic agents |
| 05/20/2009 | CN101437825A Fused heterocylic compounds and their use as mGluR5 modulators |
| 05/20/2009 | CN101437815A Polycyclic heterocyclic compounds and their use as modulators of the metabotropic glutamate 5 receptor |
| 05/20/2009 | CN101437814A Benzazepine derivatives as monoamine reuptake inhibitors |
| 05/20/2009 | CN101437813A Mglur5 modulators III |
| 05/20/2009 | CN101437798A Mglur5 modulators II |
| 05/20/2009 | CN101437794A Bicyclic tetrahydropyrrole compounds |
| 05/20/2009 | CN101437530A Aqueous tobacco leaf extract, uses thereof in the treatment of dependence |
| 05/20/2009 | CN101437513A Use of imidazo[2,1-b)]-1,3,4-thiadiazole-2-sulfonamide compounds to treat neuropathic pain |
| 05/20/2009 | CN101437510A A pharmaceutical composition useful as acetyl cholinesterase inhibitors |
| 05/20/2009 | CN101437507A Sleep inducer and stress insomnia ameliorating agent |
| 05/20/2009 | CN101434626A Compound with anti-parkinson pharmacological activity |
| 05/20/2009 | CN101434604A Condensed n-heterocyclic compounds and their use as CRF receptor antagonists |
| 05/20/2009 | CN101434596A Novel azaheterocyclic amides useful for treating pain |
| 05/20/2009 | CN101434593A Two crystal substances of baicalin, and preparations, pharmaceutical composition and uses thereof |
| 05/20/2009 | CN101434575A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 05/20/2009 | CN101434574A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 05/20/2009 | CN101434573A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 05/20/2009 | CN101433710A Nourishing medicinal liquor |
| 05/20/2009 | CN101433706A Method for preparing decoction for invigorating spleen |
| 05/20/2009 | CN101433683A Plaster for eliminating block and relieving pain |
| 05/20/2009 | CN101433678A Chinese medicinal prescription for treating Meniere's disease |
| 05/20/2009 | CN101433677A Chinese medicinal prescription for treating neurotic headache |
| 05/20/2009 | CN101433670A Medicament for treating network addiction caused by mental disorder |
| 05/20/2009 | CN101433664A Medicated health-caring wine |
| 05/20/2009 | CN101433659A Pharmaceutical composition and uses thereof |
| 05/20/2009 | CN101433646A Emergency powder for treating children's infantile convulsion |
| 05/20/2009 | CN101433645A Chinese medicine preparation for resisting depression and stress-induced mental disorder, and preparation method thereof |
| 05/20/2009 | CN101433642A Method for producing pills for inducing resuscitation, protecting liver as well as relieving or neutralizing effect of alcohol |
| 05/20/2009 | CN101433622A Fumigation lotion for treating lower limb peripheral nerve pathological changes of diabetes patient |
| 05/20/2009 | CN101433577A Mung bean sobering-up agent and preparation method thereof |
| 05/20/2009 | CN101433565A Total alkaloid extract of seeds of harmel genus and effective monomer component thereof, and preparation and use thereof |
| 05/20/2009 | CN101433550A Use of sulfur and ferric oxide for preparing medicament for treating epilepsy |
| 05/20/2009 | CN101433545A Use of bioflavanoid or polyphenolic substance for treating parkinson's disease |
| 05/20/2009 | CN101433540A Use of 3-methyl adenine in preparing medicament for treating neurodegenerative disease |
| 05/20/2009 | CN101433355A Health-care beverage with function for relieving or neutralizing effect of alcohol |
| 05/20/2009 | CN101433325A Beverage for relieving alcoholism |
| 05/20/2009 | CN101433252A Health tea with brain tonic and intelligence development functions |
| 05/20/2009 | CN100488959C Water soluble thalidomide derivative |
| 05/20/2009 | CN100488958C 3-substituted-4-pyrimidone derivatives |
| 05/20/2009 | CN100488545C Composition with functions of advancing intelligence, improving brain energetic metabolism and development and increasing dopaminergic neurons capability, and the preparing method and usage thereof |
| 05/20/2009 | CN100488506C 5-membered heterocycle derivatives, production thereof and use as medicaments |
| 05/20/2009 | CN100488494C Ophthalmologic Chinese medicine compound preparation, extracting and making methods and use thereof |
| 05/20/2009 | CN100488415C Method for preparing medication pillow of Chinese traditional medicine |